Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3Breast 3Other 2Thoracic 1Endocrine 1CNS 1

Conditions

Breast Neoplasms 3Weight Loss 1Neoplasms 1

Interventions

Trastuzumab 732Paclitaxel 695Cyclophosphamide 647Docetaxel 560Capecitabine 486Letrozole 437Fulvestrant 400Carboplatin 398Doxorubicin 341Tamoxifen 308Anastrozole 279pembrolizumab 274exemestane 258Epirubicin 251pertuzumab 240Radiotherapy 239palbociclib 224Bevacizumab 222Gemcitabine 215Vinorelbine 197Lapatinib 181130-nm albumin-bound paclitaxel 172Magnetic Resonance Spectroscopy 164Albumin-Bound Paclitaxel 157eribulin 154Surveys and Questionnaires 152Exercise 151Drug Therapy 141Taxes 134Fluorouracil 133

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Diet, Carbohydrate-Restricted × Breast × Clear all
NCT05090358 2025-10-27

Preventing High Blood Sugar in People Being Treated for Metastatic Breast Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
15 enrolled
Breast

Breast Neoplasms

NCT02744079 2020-08-31

KetoBreast

Albert Einstein College of Medicine

Phase NA Completed
11 enrolled
Breast

Breast Neoplasms, Neoplasms

NCT01559194 2014-04-14

LEAF

Ohio State University Comprehensive Cancer Center

Phase 3 Completed
82 enrolled
Breast

Breast Neoplasms, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡